ARGX:EBR
argenx SE
€750.40
arrow_downward
-1.08%(-8.20) 1D
Oct 16, 1:56:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€759.20
High
€761.80
Low
€749.80
Mkt. cap
47.00B
Avg. vol.
86.90K
Volume
15.91K
P/E ratio
31.92
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.51
Shares outstanding
35.93M
No. of employees
2K
Open
€759.20
High
€761.80
Low
€749.80
Mkt. cap
47.00B
Avg. vol.
86.90K
Volume
15.91K
P/E ratio
31.92
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.51
Shares outstanding
35.93M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
argenx sets October 22 results date as Argenx stock costs EUR 761.20
ad-hoc-news.de
·
6 hours ago
argenx schedules third-quarter results for October 22: stock pre-market at EUR 756.30
Investing.com South Africa
·
22 hours ago
Argenx shares may move 5.5% on earnings release next week By Investing.com
TipRanks
·
1 day ago
argenx Schedules Q3 2026 Results Call and Business Update
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE